Group 1 - Amgen will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 9:20 a.m. PT, featuring executives Peter Griffith and Jay Bradner [1] - The webcast of the presentation will be available on Amgen's website and archived for at least 90 days [2] - Amgen is recognized for its innovative medicines and has a strong pipeline targeting various diseases, including cancer and heart disease [3] Group 2 - In 2024, Amgen received accolades such as being named one of the "World's Most Innovative Companies" and "America's Best Large Employers" [4] - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its market significance [4]

USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and an additional site location to be announced soonInvestments will create more than 12,000 new jobs: 1,000 at Roche and more than 11,000 in support of new US manufacturing capabilities Roche already has a significant existing US presence with more than 25,000 employees, 15 R&D centres and 13 manufacturing sites Basel, ...